STOCK TITAN

Applied Molecular Transport Inc - AMTI STOCK NEWS

Welcome to our dedicated news page for Applied Molecular Transport (Ticker: AMTI), a resource for investors and traders seeking the latest updates and insights on Applied Molecular Transport.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Applied Molecular Transport's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Applied Molecular Transport's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-25.64%
Tags
conferences clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.06%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.5%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.37%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.84%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.92%
Tags
clinical trial
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.19%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.63%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.32%
Tags
management
Applied Molecular Transport Inc

Nasdaq:AMTI

AMTI Rankings

AMTI Stock Data

11.01M
31.86M
21.36%
37.28%
0.47%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States
South San Francisco

About AMTI

applied molecular transport is developing a pipeline of transformative, targeted oral biological therapeutics that promise to redefine the future of biopharmaceuticals. our deep scientific foundations in mucosal immunology and microbiome-epithelial interfaces have led to the development of powerful technology platforms that are fueling a unique pipeline of first-in-class molecules to treat a wide range of grievous diseases. our oral biopharmaceutical products mimic the biology of microbial and other natural processes that modulate health and disease via mucosal immunology pathways. our targeted therapeutics are directed to the right location to intercept disease at the point of origin of dysregulation. we are advancing a pipeline of targeted oral biological therapeutics to treat autoimmune, inflammation and other diseases, including those associated with cancer, metabolic and hepatologic disorders. our overriding patient-centric goal is to open new biological possibilities based on nov